UPDATE: Goldman Sachs Upgrades Rhythm Pharmaceuticals (RYTM) to Buy
Tweet Send to a Friend
(Updated - August 8, 2022 4:01 AM EDT)
Goldman Sachs analyst Corinne Jenkins upgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins upgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
